{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T12:01:46Z","timestamp":1783339306915,"version":"3.54.6"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011684","name":"Crohn\u2019s & Colitis Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011684","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>A prior survey disseminated in 2017 identified that healthcare access barriers exist and significantly affect patients with inflammatory bowel disease (IBD). We sought to identify, through an updated survey, the healthcare access barriers that patients continue to face, with a focus on socioeconomic factors and patient awareness of resources to navigate existing barriers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A 52-question online survey evaluating (1) access to healthcare professionals, medications, and procedures; (2) associated financial challenges; and (3) patient awareness of education and advocacy tools to navigate IBD care barriers, was disseminated through multiple channels to IBD patients and their caregivers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 2281 completed responses, patients on advanced specialty medications, younger than 65 years of age, or on employer insurance experienced significantly greater issues with insurance barriers to accessing medications and coverage of medically necessary tests\/treatments. Patients who live in areas of concentrated poverty were more likely to experience poor health outcomes when subjected to step therapy compared to patients who did not. Additionally, patients were more likely to experience one or more financial barriers or trade-offs if the patient used an advanced specialty medicine or lived in an area with concentrated poverty.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>While there have been significant and numerous advancements in IBD treatments, patients with IBD continue to experience barriers to healthcare access and treatment and financial struggles. Ongoing awareness and advocacy efforts focused on healthcare system reform and related policies to further minimize care disparities and barriers remain vital.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ibd\/izae237","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T16:26:04Z","timestamp":1728404764000},"page":"1819-1832","source":"Crossref","is-referenced-by-count":11,"title":["Healthcare Access for Patients With Inflammatory Bowel Disease in the United States: A Survey by the Crohn\u2019s &amp; Colitis Foundation"],"prefix":"10.1093","volume":"31","author":[{"given":"Ariel A","family":"Jordan","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Michigan , Ann Arbor, MI,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubha","family":"Bhat","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Cleveland Clinic Foundation , Cleveland, OH,","place":["USA"]},{"name":"Department of Digestive Disease Institute, Cleveland Clinic Foundation , Cleveland, OH,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tauseef","family":"Ali","sequence":"additional","affiliation":[{"name":"Crohn\u2019s and Colitis Center, SSM Health St. Anthony Hospital Digestive Care , Oklahoma City, OK,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R","family":"Brunskill","sequence":"additional","affiliation":[{"name":"Mathematica , Princeton, NJ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A","family":"Clusen","sequence":"additional","affiliation":[{"name":"Mathematica , Princeton, NJ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross M","family":"Maltz","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology, Hepatology and Nutrition, Nationwide Children\u2019s Hospital , Columbus, OH,","place":["USA"]},{"name":"Department of Pediatrics, The Ohio State Wexner Medical Center , Columbus, OH,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ced","family":"Moise","sequence":"additional","affiliation":[{"name":"Mathematica , Princeton, NJ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Sun","sequence":"additional","affiliation":[{"name":"Mathematica , Princeton, NJ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry J","family":"Thomas","sequence":"additional","affiliation":[{"name":"Austin Gastroenterology , Austin, TX,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassie","family":"Ray","sequence":"additional","affiliation":[{"name":"Crohn\u2019s & Colitis Foundation , New York, NY,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4521-290X","authenticated-orcid":false,"given":"Mary","family":"Harkins-Schwarz","sequence":"additional","affiliation":[{"name":"Crohn\u2019s & Colitis Foundation , New York, NY,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0841-7577","authenticated-orcid":false,"given":"Orna G","family":"Ehrlich","sequence":"additional","affiliation":[{"name":"Crohn\u2019s & Colitis Foundation , New York, NY,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"issue":"1","key":"2025070803371646400_CIT0001","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ibd\/izz104","article-title":"The cost of inflammatory bowel disease: an initiative from the Crohn\u2019s & Colitis Foundation","volume":"26","author":"Park","year":"2020","journal-title":"Inflamm Bowel Dis."},{"issue":"2","key":"2025070803371646400_CIT0002","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/MIB.0000000000000994","article-title":"The Crohn\u2019s and Colitis Foundation of America survey of inflammatory bowel disease patient health care access","volume":"23","author":"Rubin","year":"2017","journal-title":"Inflamm Bowel Dis."},{"issue":"5","key":"2025070803371646400_CIT0003","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1053\/j.gastro.2023.07.003","article-title":"Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States","volume":"165","author":"Lewis","year":"2023","journal-title":"Gastroenterology."},{"issue":"2","key":"2025070803371646400_CIT0004","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/ibd\/izac124","article-title":"The current state of care for black and hispanic inflammatory bowel disease patients","volume":"29","author":"Liu","year":"2023","journal-title":"Inflamm Bowel Dis."},{"issue":"8","key":"2025070803371646400_CIT0005","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1097\/MIB.0000000000000819","article-title":"The inflammatory bowel disease specialty medical home: a new model of patient-centered care","volume":"22","author":"Regueiro","year":"2016","journal-title":"Inflamm Bowel Dis."},{"key":"2025070803371646400_CIT0006","doi-asserted-by":"publisher","first-page":"17562848231169652","DOI":"10.1177\/17562848231169652","article-title":"Barriers to optimizing inflammatory bowel disease care in the United States","volume":"16","author":"Spencer","year":"2023","journal-title":"Therap Adv Gastroenterol."},{"issue":"11","key":"2025070803371646400_CIT0007","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1016\/j.cgh.2022.03.011","article-title":"The impact of the social determinants of health on disparities in inflammatory bowel disease","volume":"20","author":"Anyane-Yeboa","year":"2022","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"3","key":"2025070803371646400_CIT0008","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1053\/j.gastro.2020.08.064","article-title":"Effects of race and ethnicity on diagnosis and management of inflammatory bowel diseases","volume":"160","author":"Barnes","year":"2021","journal-title":"Gastroenterology."},{"issue":"7","key":"2025070803371646400_CIT0009","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.cgh.2020.05.056","article-title":"Prevalence and effects of food insecurity and social support on financial toxicity in and healthcare use by patients with inflammatory bowel diseases","volume":"19","author":"Nguyen","year":"2021","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"14","key":"2025070803371646400_CIT0010","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.12998\/wjcc.v10.i14.4327","article-title":"Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients","volume":"10","author":"Najeeb","year":"2022","journal-title":"World J Clin Cases"},{"issue":"7","key":"2025070803371646400_CIT0011","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.14309\/ajg.0000000000002720","article-title":"Insurance companies\u2019 poor adherence to guidelines for moderate-to-severe ulcerative colitis\/crohn\u2019s disease management","volume":"119","author":"Anderson","year":"2024","journal-title":"Am J Gastroenterol."},{"key":"2025070803371646400_CIT0012"},{"issue":"12","key":"2025070803371646400_CIT0013","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1093\/ibd\/izz062","article-title":"The inflammatory bowel disease medical home: from patients to populations","volume":"25","author":"Click","year":"2019","journal-title":"Inflamm Bowel Dis."},{"issue":"11","key":"2025070803371646400_CIT0014","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.cgh.2018.04.007","article-title":"Reduced unplanned care and disease activity and increased quality of life after patient enrollment in an inflammatory bowel disease medical home","volume":"16","author":"Regueiro","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"6","key":"2025070803371646400_CIT0015","first-page":"375","article-title":"Medical homes for patients with inflammatory bowel disease","volume":"13","author":"Regueiro","year":"2017","journal-title":"Gastroenterol Hepatol"},{"key":"2025070803371646400_CIT0016","author":"National Center for Health Statistics","year":"2022","journal-title":"National Health Interview Survey, 2021. Public-use data file and documentation"},{"key":"2025070803371646400_CIT0017","author":"Centers for Medicare & Medicaid Services"},{"key":"2025070803371646400_CIT0018","author":"Centers for Medicare & Medicaid Services"},{"key":"2025070803371646400_CIT0019","author":"Kaiser Family Foundation","year":"2019"},{"key":"2025070803371646400_CIT0020","year":"2014"},{"key":"2025070803371646400_CIT0021","year":"2011"},{"key":"2025070803371646400_CIT0022","author":"U.S. Census Bureau, American Community Survey 2018-2022","year":"2022"},{"key":"2025070803371646400_CIT0023","volume-title":"SAS\/STAT\u00ae 15.2 User\u2019s Guide","author":"SAS Institute Inc.","year":"2024"},{"issue":"9596","key":"2025070803371646400_CIT0024","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet."},{"key":"2025070803371646400_CIT0025","doi-asserted-by":"publisher","year":"2021","DOI":"10.15620\/cdc:100471"},{"issue":"3","key":"2025070803371646400_CIT0026","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/ibd\/izab074","article-title":"Trends in U.S. health care spending on inflammatory bowel diseases, 1996-2016","volume":"28","author":"Singh","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"12","key":"2025070803371646400_CIT0027","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1093\/ibd\/izz059","article-title":"The role of early biologic therapy in inflammatory bowel disease","volume":"25","author":"Berg","year":"2019","journal-title":"Inflamm Bowel Dis."},{"issue":"5","key":"2025070803371646400_CIT0028","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology."},{"issue":"9","key":"2025070803371646400_CIT0029","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.14309\/ajg.0000000000002345","article-title":"A narrative review of financial burden, distress, and toxicity of inflammatory bowel diseases in the United States","volume":"118","author":"Kahn-Boesel","year":"2023","journal-title":"Am J Gastroenterol."},{"issue":"10","key":"2025070803371646400_CIT0030","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1093\/ibd\/izz013","article-title":"Advocating for patients with inflammatory bowel disease: how to navigate the prior authorization process","volume":"25","author":"Bhat","year":"2019","journal-title":"Inflamm Bowel Dis."},{"issue":"10","key":"2025070803371646400_CIT0031","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1093\/ibd\/izad012","article-title":"Delays in therapy associated with current prior authorization process for the treatment of inflammatory bowel disease","volume":"29","author":"Choi","year":"2023","journal-title":"Inflamm Bowel Dis."},{"issue":"9","key":"2025070803371646400_CIT0032","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1093\/ibd\/izad088","article-title":"Prior authorization of biologics in the management of inflammatory bowel disease","volume":"29","author":"Loeb","year":"2023","journal-title":"Inflamm Bowel Dis."},{"issue":"12","key":"2025070803371646400_CIT0033","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1007\/s10620-023-08098-7","article-title":"Insurance approval delay of biologic therapy dose escalation associated with disease activity in patients with inflammatory bowel disease","volume":"68","author":"Shah","year":"2023","journal-title":"Dig Dis Sci."},{"issue":"5","key":"2025070803371646400_CIT0034","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.cgh.2024.01.050","article-title":"White Paper AGA: American Gastroenterological Association Position Statement: the future of IBD care in the United States-removing barriers and embracing opportunities","volume":"22","author":"Sofia","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"2025070803371646400_CIT0035","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1097\/MIB.0000000000001153","article-title":"Variations in health insurance policies regarding biologic therapy use in inflammatory bowel disease","volume":"23","author":"Yadav","year":"2017","journal-title":"Inflamm Bowel Dis."},{"issue":"6","key":"2025070803371646400_CIT0036","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1097\/MCG.0000000000001144","article-title":"Variations in insurance policies regarding adherence to the AGA guideline for therapeutic drug monitoring in IBD","volume":"53","author":"Yadav","year":"2019","journal-title":"J Clin Gastroenterol."},{"issue":"15","key":"2025070803371646400_CIT0037","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.3748\/wjg.v21.i15.4457","article-title":"Tools for primary care management of inflammatory bowel disease: do they exist","volume":"21","author":"Bennett","year":"2015","journal-title":"World J Gastroenterol."},{"issue":"3","key":"2025070803371646400_CIT0038","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11894-024-00916-w","article-title":"Advanced therapies for inflammatory bowel disease: navigating payor and financial challenges","volume":"26","author":"Whitmire","year":"2024","journal-title":"Curr Gastroenterol Rep."},{"issue":"1","key":"2025070803371646400_CIT0039","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jnma.2023.09.009","article-title":"Delay in prior authorization of biologic therapy: another possible cause of healthcare disparity in IBD patients","volume":"116","author":"Rao","year":"2024","journal-title":"J Natl Med Assoc."},{"issue":"12","key":"2025070803371646400_CIT0040","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1093\/ibd\/izac022","article-title":"A mixed-methods assessment of the impact of insurance issues on the emotional and physical health of patients with inflammatory bowel disease","volume":"28","author":"Philippou","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"4","key":"2025070803371646400_CIT0041","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/MOG.0000000000000855","article-title":"Inflammatory bowel disease in underserved populations: lessons for practice","volume":"38","author":"Odufalu","year":"2022","journal-title":"Curr Opin Gastroenterol."},{"issue":"9","key":"2025070803371646400_CIT0042","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/ibd\/izad194","article-title":"Racial and ethnic disparities in patients with inflammatory bowel disease: an online survey","volume":"30","author":"Shah","year":"2024","journal-title":"Inflamm Bowel Dis."},{"issue":"6","key":"2025070803371646400_CIT0043","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/ibd\/izac161","article-title":"Racial difference in efficacy of golimumab in ulcerative colitis","volume":"29","author":"Greywoode","year":"2023","journal-title":"Inflamm Bowel Dis."},{"key":"2025070803371646400_CIT0044","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/17562848221079162","article-title":"Social barriers influence inflammatory bowel disease (IBD) outcomes and disproportionally affect Hispanics and non-Hispanic Blacks with IBD","volume":"15","author":"Damas","year":"2022","journal-title":"Ther Adv Gastroenter."},{"issue":"1","key":"2025070803371646400_CIT0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-22429-z","article-title":"Socioeconomic status and race are both independently associated with increased hospitalization rate among Crohn\u2019s disease patients","volume":"8","author":"Walker","year":"2018","journal-title":"Sci Rep."},{"issue":"3","key":"2025070803371646400_CIT0046","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/fampra\/cmy078","article-title":"Caring for veterans in US Civilian Primary Care: qualitative interviews with primary care providers","volume":"36","author":"Vest","year":"2019","journal-title":"Fam Pract."},{"issue":"8","key":"2025070803371646400_CIT0047","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1097\/MLR.0000000000000172","article-title":"Barriers to care in an ethnically diverse publicly insured population: is health care reform enough","volume":"52","author":"Call","year":"2014","journal-title":"Med Care."},{"issue":"1","key":"2025070803371646400_CIT0048","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/07370016.2018.1404832","article-title":"Barriers to health care access for low income families: a review of literature","volume":"35","author":"Lazar","year":"2018","journal-title":"J Community Health Nurs."},{"issue":"11","key":"2025070803371646400_CIT0049","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.3390\/nu11112657","article-title":"Enteral nutrition in patients with inflammatory bowel disease. Systematic review, meta-analysis, and meta-regression","volume":"11","author":"Comeche","year":"2019","journal-title":"Nutrients"},{"issue":"3","key":"2025070803371646400_CIT0050","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11894-023-00913-5","article-title":"Biosimilars in IBD: what every clinician needs to know","volume":"26","author":"Angyal","year":"2024","journal-title":"Curr Gastroenterol Rep."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izae237\/59603033\/izae237.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/7\/1819\/59603033\/izae237.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/7\/1819\/59603033\/izae237.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T07:37:26Z","timestamp":1751960246000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/31\/7\/1819\/7811812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,10,8]]},"published-print":{"date-parts":[[2025,7,7]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izae237","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2024,10,8]]}}}